Pentasa 500 mg

Informazioni principali

  • Nome commerciale:
  • Pentasa 500 mg Deposito-Tabletten
  • Forma farmaceutica:
  • Deposito-Tabletten
  • Composizione:
  • mesalazinum 500 mg, excipiens pro compresso.
  • Utilizzare per:
  • Esseri umani
  • Tipo di medicina:
  • Farmaco biologico

Documenti

  • per i professionisti:
  • Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.


    Richiedi il foglio illustrativo per i professionisti.

Localizzazione

  • Disponibile in:
  • Pentasa 500 mg Deposito-Tabletten
    Svizzera
  • Lingua:
  • italiano

Informazioni terapeutiche

  • Gruppo terapeutico:
  • Synthetika
  • Area terapeutica:
  • Colite ulcerosa

Altre informazioni

Status

  • Fonte:
  • Swissmedic - Swiss Agency for Therapeutic Products
  • Numero dell'autorizzazione:
  • 47502
  • Data dell'autorizzazione:
  • 25-09-1989
  • Ultimo aggiornamento:
  • 19-10-2018

Foglio illustrativo: composizione, posologia, indicazioni, interazioni, gravidanza, allattamento, effetti indesiderati, controindicazioni

Patienteninformation

Quali effetti collaterali può avere Pentasa compresse depot/granulato depot?

Pentasa® Compresse Depot/Granulato Depot

Che cos'è Pentasa compresse depot/granulato depot e quando si usa?

Pentasa è un medicamento per il trattamento di malattie infiammatorie del colon. Somministrato

nella fase acuta, il preparato ha un effetto antinfiammatorio ed evita o ritarda la ricomparsa di

infiammazioni del colon. Pentasa si può impiegare solo su prescrizione medica.

Di che cosa occorre inoltre tener conto durante il trattamento?

Pentasa agisce anche in caso di diarrea. Tuttavia, bisogna informare il medico di questa condizione.

Quando non si può usare Pentasa compresse depot/granulato depot?

Non assumere Pentasa in caso di ipersensibilità alla mesalazina, ad altri componenti del preparato o

ai salicilati (es. Aspirina).

Non devono usare Pentasa i bambini al disotto dei 2 anni, i pazienti affetti da ulcere gastriche e

duodenali, i pazienti con tendenza troppo elevata alle emorragie e quelli con gravi disfunzioni

epatiche e renali.

Quando è richiesta prudenza nella somministrazione di Pentasa compresse depot/granulato depot?

Questo medicamento può ridurre la capacità di reazione, la capacità di condurre un veicolo e la

capacità di utilizzare attrezzi o macchine!

In caso di disfunzioni del fegato o dei reni, Pentasa può essere assunto solo con prudenza,

controllando i valori del fegato e dei reni nel sangue.

Sono possibili interazioni con medicamenti contenenti il principio attivo azatioprina, tioguanina (un

medicamento contro certi tipi di cancro) o mercaptopurina (per il trattamento di malattie del sistema

immunitario); l'azione dell'azatioprina o della mercaptopurina può essere potenziata.

L'effetto di abbassamento della glicemia dei medicamenti antidiabetici può risultare potenziato. La

tollerabilità del metotrexate (medicamento contro determinati tumori) può essere diminuita (effetti

collaterali più severi).

L'azione dei medicamenti che favoriscono l'eliminazione dell'acido urico può essere diminuita.

Similmente, può essere diminuita l'azione di medicamenti diuretici e indebolita quella della

rifampicina (medicamento contro la tubercolosi).

L'azione dei medicamenti anticoagulanti può risultare potenziata.

Gli effetti indesiderati specifici a carico dello stomaco (irritazione della mucosa gastrica) dei

preparati cortisonici possono risultare più severi.

Informi il suo medico o il suo farmacista nel caso in cui soffre di altre malattie, soffre di allergie o

assume altri medicamenti (anche se acquistati di sua iniziativa!).

Si può assumere Pentasa compresse depot/granulato depot durante la gravidanza e l'allattamento?

Durante la gravidanza e l'allattamento, Pentasa può essere impiegato solo dopo esplicita

autorizzazione del medico curante.

Pentasa passa nel latte materno. Informi il suo medico se ha in programma o in corso una gravidanza

oppure se allatta il suo bambino.

Come usare Pentasa compresse depot/granulato depot?

Le compresse Pentasa Depot: vanno assunte durante i pasti, con un po’ di liquido.

Le compresse Depot da 500 mg hanno un’incisione centrale e possono essere divise. Le compresse

Depot da 1 g non hanno un’incisione centrale e non possono essere divise. In caso di difficoltà di

deglutizione lasciar sciogliere le compresse Depot in un cucchiaio o un bicchiere d'acqua e poi

assumerle immediatamente. Non polverizzare né masticare le compresse Depot.

Granulato Pentasa Depot: svuotare direttamente in bocca il contenuto di una bustina e deglutirlo con

del liquido. Non masticare.

Adulti

Dosaggio nelle malattie infiammatorie intestinali acute:

Compresse Depot da 500 mg: 6-8 compresse Depot, ripartite in 2-4 dosi singole al giorno.

Compresse Depot da 1 g: 3-4 compresse Depot, ripartite in 2-4 dosi singole al giorno.

Granulato Depot da 1 g e da 2 g: 3-4 bustine, ripartiti in 2-4 dosi singole al giorno.

In casi speciali, il medico può prescrivere una posologia differente da questo schema.

Dosaggio per la prevenzione delle ricadute:

Compresse Depot da 500 mg: ½ compressa Depot, 3 volte al giorno.

Bambini e adolescenti

Trattamento delle malattie infiammatorie intestinali acute e prevenzione delle ricadute.

La posologia va stabilita dal medico individualmente.

I bambini di età inferiore ai 2 anni non devono assumere Pentasa.

Non modifichi di propria iniziativa la posologia prescritta. Se ritiene che l’azione del medicamento

sia troppo debole o troppo forte ne parli al suo medico o al suo farmacista.

Quali effetti collaterali può avere Pentasa compresse depot/granulato depot?

Con l’assunzione di Pentasa possono manifestarsi i seguenti effetti collaterali:

Raramente, durante una terapia con Pentasa, possono comparire reazioni d'ipersensibilità

indipendenti dalla dose, quali eruzioni cutanee, aumentata sensibilità della pelle alla luce solare e ai

raggi ultravioletti (fotosensibilità, severe reazioni sono state riportate nei pazienti con preesistente

dermatite atopica/eczema), febbre, crampi dei muscoli bronchiali (broncospasmo) e altre reazioni

allergiche. Occasionalmente compaiono mal di testa, vertigini, disturbi gastrointestinali quali nausea,

vomito, diarrea, dolori addominali, flatulenza ed eruzioni cutanee (orticaria, arrossamento).

Raramente, possono comparire infiammazione del cuore e infiammazione acuta del pancreas.

Molto raramente, possono comparire caduta dei capelli passeggera, reazioni tipo lupus eritematoso

(una malattia autoimmunitaria), aumento degli enzimi epatici e dei valori di bilirubina, malattie del

fegato (epatite, cirrosi, insufficienza epatica), lesioni renali, anormale colorazione delle urine,

reazioni allergiche polmonari (es. tosse, affanno, infiammazione degli alveoli), dolori articolari e

muscolari, riduzione temporanea della produzione spermatica e alterazioni del quadro ematico.

Se compare uno di questi effetti collaterali o altri segni qui non descritti dovrebbe informare il suo

medico o il suo farmacista.

Di che altro occorre tener conto?

Le compresse Pentasa Depot presentano delle macchioline marroni. Questa colorazione è normale e

caratterizza le proprietà speciali di Pentasa che permettono il rilascio ritardato del principio attivo

nell’intestino.

Conservare Pentasa Compresse Depot e Pentasa Granulato Depot nella confezione originale, al

riparo dalla luce, a temperatura ambiente (15-25°C).

Tenere il medicamento fuori dalla portata dei bambini.

Il medicamento non dev’essere ultilizzato oltre la data indicata con «Exp.» sul contenitore.

Il medico o il farmacista, che sono in possesso di un’informazione professionale dettagliata, possono

darle ulteriori infomazioni.

Cosa contiene Pentasa compresse depot/granulato depot?

1 compressa Depot contiene 500 mg o 1 g del principio attivo mesalazina e sostanze ausiliarie.

Una bustina di granulato Depot contiene 1 g o 2 g del principio attivo mesalazina e sostanze

ausiliarie.

Numero dell’omologazione

47502, 53431 (Swissmedic)

Dov’è ottenibile Pentasa compresse depot/granulato depot? Quali confezioni sono disponibili?

In farmacia, dietro presentazione della prescrizione medica.

Compresse Depot da 500 mg: confezioni da 100 e 300 compresse.

Compresse Depot da 1 g: confezioni da 60 compresse.

Granulato Depot da 1 g: confezioni da 50 e 150 bustine.

Granulato Depot da 2 g: confezioni da 60 bustine.

Titolare dell’omologazione

Ferring AG, 6340 Baar

Questo foglietto illustrativo è stato controllato l’ultima volta nel gennaio 2018 dall’autorità

competente in materia di medicamenti (Swissmedic).

16-1-2019

Safety and efficacy of 3‐phytase FSF10000 as a feed additive for chickens for fattening or reared for laying, laying hens and minor poultry species

Safety and efficacy of 3‐phytase FSF10000 as a feed additive for chickens for fattening or reared for laying, laying hens and minor poultry species

Published on: Tue, 15 Jan 2019 The additive 3‐phytase FSF10000 is a solid product that contains a 3‐phytase produced by a genetically modified strain of Komagataella phaffii. A liquid formulation of the additive has been previously assessed by the EFSA Panel on Additives and Products of Substances used in Animal Feed (FEEDAP) and is currently authorised as a feed additive for poultry species. The applicant requested for the use of this new formulation of the additive in chickens for fattening or reared ...

Europe - EFSA - European Food Safety Authority EFSA Journal

12-1-2019

Assessment of the application for renewal of authorisation of selenomethionine produced by Saccharomyces cerevisiae NCYC R397 for all animal species

Assessment of the application for renewal of authorisation of selenomethionine produced by Saccharomyces cerevisiae NCYC R397 for all animal species

Published on: Fri, 11 Jan 2019 The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the application for renewal of authorisation of organic form of selenium produced by Saccharomyces cerevisiae NCYC R397 (Alkosel®) for all animal species. The FEEDAP Panel has delivered two opinions (on 2007 and 2016) on the safety and efficacy of the additive. The additive is characterised as organic selenium mainly selenomethionine (63%); it was ini...

Europe - EFSA - European Food Safety Authority EFSA Journal

6-1-2019

Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g

Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g

Lupin Pharmaceuticals, Inc. is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, 1g and 3 lots of Ceftriaxone for Injection, USP 2g, to the hospital/physician level. The products have been found to contain visual grey particulate matter in reconstituted vials.

FDA - U.S. Food and Drug Administration

23-11-2018

FDA Classifies Field Action Related to Fc 500™ And Epics® As Class 1 Recall Beckman Coulter Life Sciences Committed to Helping Customers Take Prompt, Appropriate Actions

FDA Classifies Field Action Related to Fc 500™ And Epics® As Class 1 Recall Beckman Coulter Life Sciences Committed to Helping Customers Take Prompt, Appropriate Actions

Beckman Coulter Life Sciences today announced the previously communicated global voluntary recall launched in January 2018 related to the FC 500™ Series Flow Cytometers (FC 500), COULTER® EPICS® XL™ and COULTER® EPICS® XL-MCL™ Flow Cytometer with System II Software (together referred to as the EPICS) has been classified as Class 1 by the U.S. Food and Drug Administration (FDA).

FDA - U.S. Food and Drug Administration

22-11-2018

Foreign Product Alert: Black Ant King tablets, Gold Viagra 9800mg capsules, LIPRO Dietary capsules, Stree Overlord Strong tablets (pills), Vegetal Vigra capsules, ViaGro 500mg Male Enhancement capsules

Foreign Product Alert: Black Ant King tablets, Gold Viagra 9800mg capsules, LIPRO Dietary capsules, Stree Overlord Strong tablets (pills), Vegetal Vigra capsules, ViaGro 500mg Male Enhancement capsules

These foreign health products have been found by regulators in other countries to contain undeclared drug ingredients.

Health Canada

21-11-2018

Setting of an import tolerance for mandipropamid in cocoa beans

Setting of an import tolerance for mandipropamid in cocoa beans

Published on: Tue, 20 Nov 2018 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Syngenta Agro GmbH submitted a request to the competent national authority in Austria to set a maximum residue level (MRL) for the active substance mandipropamid in cocoa beans imported from Nigeria and Cameroon. The data submitted in support of the request were found to be sufficient to derive a MRL proposal of 0.06 mg/kg. Adequate analytical methods for enforcement are available to control the res...

Europe - EFSA - European Food Safety Authority Publications

31-10-2018

Efficacy of Bergazym® P100 (endo‐1,4‐β‐xylanase) as a feed additive for chickens for fattening and weaned piglets

Efficacy of Bergazym® P100 (endo‐1,4‐β‐xylanase) as a feed additive for chickens for fattening and weaned piglets

Published on: Tue, 30 Oct 2018 00:00:00 +0100 The product Bergazym® P100 contains a xylanase which is produced by a non‐genetically modified strain of Trichoderma reesei. The additive is available in a coated granular form and it is intended to be used as a zootechnical additive (functional group: digestibility enhancers) for chickens for fattening, and weaned piglets at the dose of 1,500 EPU/kg feed. The production strain and the additive were fully characterised in a previous assessment of the Panel o...

Europe - EFSA - European Food Safety Authority Publications

24-10-2018

Safety and efficacy of Hostazym® X (endo‐1,4‐beta‐xylanase) as a feed additive for sows in order to have benefit in piglets

Safety and efficacy of Hostazym® X (endo‐1,4‐beta‐xylanase) as a feed additive for sows in order to have benefit in piglets

Published on: Tue, 23 Oct 2018 00:00:00 +0200 Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of HOSTAZYM® X as a feed additive for sows in order to have benefit in piglets. The additive HOSTAZYM® X contains endo‐1,4‐beta‐xylanase and is available in liquid and solid formulations. This product is authorised as a feed additive for chickens for fattening, tu...

Europe - EFSA - European Food Safety Authority Publications

1-10-2018

Public Notification: FX75000 contains hidden drug ingredient

Public Notification: FX75000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use FX75000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

31-7-2018

Public Notification: Black Rhino 25000 contains hidden drug ingredient

Public Notification: Black Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Black Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

31-7-2018

Public Notification: Krazzy Rhino 25000 contains hidden drug ingredient

Public Notification: Krazzy Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Krazzy Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

31-7-2018

Public Notification: Gold Rhino 25000 contains hidden drug ingredient

Public Notification: Gold Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Gold Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

31-7-2018

Public Notification: Platinum Rhino 25000 contains hidden drug ingredient

Public Notification: Platinum Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Platinum Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

13-7-2018

Hospira Issues Voluntary Nationwide Recall of Daptomycin for Injection Lyophilized Powder for Solution, Due to Infusion Reactions

Hospira Issues Voluntary Nationwide Recall of Daptomycin for Injection Lyophilized Powder for Solution, Due to Infusion Reactions

Hospira, Inc., a Pfizer company, is voluntarily recalling 8 lots of Hospira’s Daptomycin for Injection 500 mg, Lyophilized Powder For Solution, Single Dose Vial (NDC 0409-0106-01) to the Hospital/Retail level. The product is being recalled due to adverse event reports indicative of infusion reactions.

FDA - U.S. Food and Drug Administration

10-7-2018

Preventieve HIV-remmers (PrEP) worden verstrekt voor een periode van vijf jaar

Preventieve HIV-remmers (PrEP) worden verstrekt voor een periode van vijf jaar

PrEP wordt binnen een onderzoekssetting voor een periode van vijf jaar verstrekt aan de hoogrisicogroep van mannen die seks hebben met mannen (MSM). Dat heeft minister Bruno Bruins (Medische Zorg) vandaag bekend gemaakt. Op basis van schattingen van het RIVM zullen ongeveer 6500 mannen hiervan gebruik gaan maken en kunnen hiermee  250 hiv-infecties per jaar worden voorkomen. Voor gebruikers gaat een eigen bijdrage gelden van maximaal 25%, dat komt overeen met ongeveer 12 euro per maand. Ook wordt hen gev...

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

26-6-2018

Huish Outdoors recalls Oceanic and Hollis Scuba Diving Regulators

Huish Outdoors recalls Oceanic and Hollis Scuba Diving Regulators

The scuba diving regulators can restrict airflow at low tank pressures (below 500 psi), posing a drowning hazard to divers.

Health Canada

22-6-2018

Metronidazole intravenous infusion 500 mg/100 mL bag

Metronidazole intravenous infusion 500 mg/100 mL bag

Shortage and althernative supply of Metronidazole intravenous infusion 500 mg/100 mL bag

Therapeutic Goods Administration - Australia

20-6-2018

Public Notification: Black Stallion 35000 contains hidden drug ingredient

Public Notification: Black Stallion 35000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Black Stallion 35000, a product promoted for sexual enhancement. This product was identified by FDA during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

21-5-2018

Melanie Wholesale Inc. Issues Allergy Alert on Undeclared Peanuts in Melanie Mini Cookies with Caramel Flavor

Melanie Wholesale Inc. Issues Allergy Alert on Undeclared Peanuts in Melanie Mini Cookies with Caramel Flavor

Melanie Wholesale Inc. of Brooklyn, NY is recalling its 17.6 oz (500g) package of “Melanie Mini Cookies with Caramel Flavor”, because they contain undeclared peanuts. People who have allergies to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products.

FDA - U.S. Food and Drug Administration

21-5-2018

Melanie Wholesale Issues Allergy Alert on Undeclared Peanuts in Cookies

Melanie Wholesale Issues Allergy Alert on Undeclared Peanuts in Cookies

Melanie Wholesale Inc. of Brooklyn, NY is recalling its 17.6 oz (500g) package of “Melanie Liubitelskie Cookies”, because they contain undeclared peanuts. People who have allergies to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products.

FDA - U.S. Food and Drug Administration

18-5-2018

7K and Poseidon 4500 by Shoreside Enterprises: Voluntary Recall - Due to Presence of Undeclared Sildenafil and/or Tadalafil

7K and Poseidon 4500 by Shoreside Enterprises: Voluntary Recall - Due to Presence of Undeclared Sildenafil and/or Tadalafil

Use of products with the undeclared active ingredients, sildenafil and tadalafil, may pose a threat to consumers because the active ingredient may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may cause a significant drop in blood pressure that may be life threatening. Among the adult male population who are most likely to use these products, adult males who use nitrates for cardiac conditions are the most at risk from these products. These products are considered ta...

FDA - U.S. Food and Drug Administration

17-5-2018

Shoreside Enterprises Issues Voluntary Nationwide Recall of 7K and Poseidon 4500 (Extreme 1000 Mg) Due to Presence of Undeclared Sildenafil and Tadalafil

Shoreside Enterprises Issues Voluntary Nationwide Recall of 7K and Poseidon 4500 (Extreme 1000 Mg) Due to Presence of Undeclared Sildenafil and Tadalafil

Shoreside Enterprises, Inc. is voluntarily recalling 7K (Lot specific: Lot #RO) and Poseidon 4500 (Extreme 1000 mg) (Lot specific: Lot #20117BL) to the consumer level. FDA analysis found the samples of these products to contain undeclared Sildenafil and/or Tadalafil. Sildenafil and Tadalafil are active ingredients in two FDA-approved prescription drugs used for the treatment of erectile dysfunction (ED).

FDA - U.S. Food and Drug Administration

18-4-2018

ViaGro 500mg Male Enhancement capsules

ViaGro 500mg Male Enhancement capsules

Safety advisory

Therapeutic Goods Administration - Australia

14-4-2018

'Rhino 69 Extreme 50000' Recalled due to Presence of Active Ingredient 'Tadalafil'

'Rhino 69 Extreme 50000' Recalled due to Presence of Active Ingredient 'Tadalafil'

AMA Wholesale Inc. (Distributor/Re-seller), is voluntarily recalling Rhino 69 Extreme 50000 capsules to the consumer level. FDA analysis found the product to be tainted with undeclared tadalafil. Tadalafil is an active ingredient in a FDA-approved prescription drug that is used for erectile dysfunction.

FDA - U.S. Food and Drug Administration

28-3-2018

Public Notification: Rhino 69 Extreme 50000 contains hidden drug ingredient

Public Notification: Rhino 69 Extreme 50000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Rhino 69 Extreme 50000, a product promoted and sold for sexual enhancement on various websites, including www.bonanza.com, and possibly in some retail stores.

FDA - U.S. Food and Drug Administration

25-9-2017

Global operation against illegal medicines

Global operation against illegal medicines

A global operation against illegal medicines has been completed. 123 countries participated, and the operation resulted in 354 arrests or further investigations and the suspension of more than 3,500 websites.

Danish Medicines Agency

28-11-2018

PHEBURANE (Eurocept International BV)

PHEBURANE (Eurocept International BV)

PHEBURANE (Active substance: Sodium Phenylbutyrate) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)8043 of Wed, 28 Nov 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2500/T/20

Europe -DG Health and Food Safety

20-11-2018

.@US_FDA issues Class I Medical Device Recall, the most serious type of recall: Beckman Coulter Life Sciences Beckman Coulter Life Sciences recalls the FC500 Series Flow Cytometers and EPICS XL Series Flow Cytometers. Find out more:  https://go.usa.gov/xP

.@US_FDA issues Class I Medical Device Recall, the most serious type of recall: Beckman Coulter Life Sciences Beckman Coulter Life Sciences recalls the FC500 Series Flow Cytometers and EPICS XL Series Flow Cytometers. Find out more: https://go.usa.gov/xP

. @US_FDA issues Class I Medical Device Recall, the most serious type of recall: Beckman Coulter Life Sciences Beckman Coulter Life Sciences recalls the FC500 Series Flow Cytometers and EPICS XL Series Flow Cytometers. Find out more: https://go.usa.gov/xPAtn  #MedicalDevice #FDA pic.twitter.com/6e064UQ2wg

FDA - U.S. Food and Drug Administration

5-6-2018

Liste di Trasparenza (aggiornamento del 15/05/2018)

Liste di Trasparenza (aggiornamento del 15/05/2018)

Facendo seguito alla Sentenza Tar Lazio n.12615 del 22 dicembre 2017, che ha annullato l’inserimento nella lista di trasparenza del medicinale Pentasa nella confezione con codice AIC n. 027130071, si comunica che è disponibile l’aggiornamento dell’elenco dei prodotti medicinali equivalenti che modifica i precedenti elenchi pubblicati sul sito AIFA con i prezzi di riferimento aggiornati al 15 maggio 2018.

Italia - AIFA - Agenzia Italiana del Farmaco